LMSSitesePortfolio註冊登入
位置 : 首頁 > 最新文章
編號 標題 社群 人氣 建立時間
4312 P-12 Unveiling MYCN Regulatory Networks in Neuroblastoma by Integrative Analysis of Heterogeneous Genomics Data 508 10-11 00:17
4311 P-11 Integrative genomic analyses reveal aberrant nucleotide and amino acid metabolism in high-risk neuroblastoma 532 10-11 00:14
4310 P-10 The Hippo Pathway and Neuroblastomas 553 11-04 13:36
4309 P-09 Proteomic analysis of high-risk neuroblastoma identifies nuclear distribution protein C as a marker of differentiation and prognosis 532 10-11 00:08
4308 P-08 DC-Dependent efficient prevention of spontaneous neuroblastoma in MYCN transgenic mice 449 10-10 23:47
4307 P-07 Expression of MYCN mRNA in early neuroblastoma development of MYCN-transgenic mice 491 10-10 23:43
4306 P-06 H1FX is a potent downstream factor of midkine in neuroblastoma 604 10-10 23:39
4305 P-05 Neuroblastoma sphere specific gene regulates stemness pathway for cancer stem cells 566 10-10 23:37
4304 P-04 Feasibility of delayed local control treatment in patient with high risk Neuroblastoma: Report of a pilot study from the Japan Neuroblastoma study group(JN-H-05) 546 10-10 23:34
4303 P-03 KIR-ligand incompatibility in the graft-versus-host direction improves progression-free survival in patients with primary high risk neuroblastoma after umbilical cord blood transplantation 563 10-10 23:25
4302 P-02 Determination of timing of surgery based on IDRF: an observation study for low risk neuroblastomas (JN-L-10) 522 11-10 23:23
4301 P-01 Effects of MAPK inhibitors on neuroblastoma 616 10-10 23:18
4300 O-12 Identification of ALK-binding phosphotyrosine-containing proteins as the critical regulators of oncgenic properties of Neuroblastoma cells 484 10-10 23:15
4299 O-11 The Roles of Innate Immunity in the Treatment of Neuroblastoma 531 10-10 23:13
4298 O-10 Epigenetic and gene expression analysis of the crucial early events for neuroblastoma tumorigenesis in MYCN-Tg mice 772 10-10 23:11
4297 O-09 Genomic characterization of aggressive subtypes of neuroblastoma with 11q partial loss 443 10-10 23:08
4296 O-08 Update the roles of glycolytic inhibitors in the treatment of neuroblastoma 375 10-10 23:05
4295 O-07 ALK inhibition enhances NLRR1/EGFR pathway dependency with nucleolus alteration in neuroblastoma 476 10-10 23:02
4294 O-06 Unusual Suspects Identified in Neuroblastoma – An Unexpected Cell Death Pathway 403 10-10 22:58
4293 O-05 A new therapeutic strategy of neuroblastoma by Liquid biopsy 508 10-10 22:54
Prev567891011121314Next Go: / 94